Literature DB >> 12088100

Changes in apoptosis, mitosis, Her-2, p53 and Bcl2 expression in breast carcinomas after short-term tamoxifen treatment.

E Farczádi1, I Kaszás, M Baki, B Szende.   

Abstract

The short-term (7 days) effect of tamoxifen on apoptosis and mitosis index, p53, Bcl2 and Her-2/neu/c-erb2 expression in invasive ductal mammary carcinoma was studied histologically in the diagnostic biopsy and surgically removed tumor tissue of 10 patients. Following tamoxifen treatment expression of HER-2 and p53 decreased but Bcl2 remained unchanged. Mitotic activity decreased slightly, but not significantly. Apoptotic activity increased in six cases in the second sample compared to the values measured of the first biopsy. These changes may be attributed to the effect of antiestrogen therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088100

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  3 in total

1.  Gap junctions: the claymore for cancerous cells.

Authors:  Masoud Asadi-Khiavi; Hossein Hamzeiy; Sajjad Khani; Ailar Nakhlband; Jaleh Barar
Journal:  Bioimpacts       Date:  2011-07-31

2.  Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.

Authors:  Baljit Singh; Julia A Smith; Deborah M Axelrod; Pietro Ameri; Heather Levitt; Ann Danoff; Martin Lesser; Cristina de Angelis; Irineu Illa-Bochaca; Sara Lubitz; Daniel Huberman; Farbod Darvishian; David L Kleinberg
Journal:  Breast Cancer Res       Date:  2014-11-11       Impact factor: 6.466

3.  E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter.

Authors:  Junjun Chu; Yinghua Zhu; Yujie Liu; Lijuan Sun; Xiaobin Lv; Yanqin Wu; Pengnan Hu; Fengxi Su; Chang Gong; Erwei Song; Bodu Liu; Qiang Liu
Journal:  Oncotarget       Date:  2015-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.